Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Norofumi Hattori"'
Autor:
Mitsuro Kanda, Dai Shimizu, Kazushi Miyata, Osamu Maeda, Chie Tanaka, Yoshikuni Inokawa, Norofumi Hattori, Masamichi Hayashi, Masahiko Ando, Yachiyo Kuwatsuka, Kenta Murotani, Goro Nakayama, Masahiko Koike, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera
Publikováno v:
Contemporary Clinical Trials Communications, Vol 24, Iss , Pp 100853- (2021)
In Japan, esophagectomy after two courses of 5-fluorouracil plus cisplatin is regarded a standard strategy for treating resectable stage II or III esophageal squamous cell carcinoma (ESCC). However, 5-fluorouracil plus cisplatin does not benefit coho
Externí odkaz:
https://doaj.org/article/60bd584ed5604ef4b37d38428dccd043
Autor:
Yachiyo Kuwatsuka, Norofumi Hattori, Kenta Murotani, Kazushi Miyata, Yoshikuni Inokawa, Mitsuro Kanda, Tomoki Ebata, Chie Tanaka, Masamichi Hayashi, Dai Shimizu, Osamu Maeda, Masahiko Koike, Goro Nakayama, Yasuhiro Kodera, Masahiko Ando, Yuichi Ando
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 24, Iss, Pp 100853-(2021)
Contemporary Clinical Trials Communications, Vol 24, Iss, Pp 100853-(2021)
In Japan, esophagectomy after two courses of 5-fluorouracil plus cisplatin is regarded a standard strategy for treating resectable stage II or III esophageal squamous cell carcinoma (ESCC). However, 5-fluorouracil plus cisplatin does not benefit coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bf3c1cbcfbaf3c07a487e1a8e4d7c7
http://europepmc.org/articles/PMC8601964
http://europepmc.org/articles/PMC8601964